Physician profile
Daniel Ilinsky
NPI 1750885166
$2,623.47
in general payments reported to CMS, 2019-2025
22 companies · $650 in 2025
The $650 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $895 · 2024: $1,078 · 2025: $650.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,608 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $15.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,608.47 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $15.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coloplast Corp | $834.04 | 2023-2024 | Titan, Virtue |
| Teleflex LLC | $331.31 | 2023-2025 | Urolift, Barrigel |
| Davol INC. | $212.69 | 2023-2024 | Arista Ah Flexitip |
| Boston Scientific Corporation | $197.29 | 2023-2024 | Rezum Generator |
| Abbvie INC. | $187.67 | 2023-2025 | |
| Accord Healthcare, INC. | $175.14 | 2024-2025 | |
| Janssen Biotech, INC. | $123.61 | 2024-2025 | Erleada, Balversa, Akeega |
| Biotissue Holdings INC. | $115.93 | 2024 | |
| Bluewind Medical | $68.70 | 2024 | Revi |
| Sumitomo Pharma America, INC. | $52.82 | 2024-2025 | Gemtesa |
| Urogen Pharma, INC. | $48.48 | 2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $42.38 | 2025 | |
| Caris Mpi, INC. | $41.97 | 2025 | Mi Cancer Seek |
| Merck Sharp & Dohme LLC | $28.53 | 2025 | Keytruda |
| Dendreon Pharmaceuticals LLC | $27.73 | 2025 | Provenge |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Progenics Pharmaceuticals, INC. | $24.84 | 2023 | Pylarify |
| Medtronic, INC. | $24.53 | 2025 | Altaviva |
| Innovation Technologies INC | $19.77 | 2024 | Irrisept |
| Telix Pharmaceuticals | $19.26 | 2024 | Illuccix |
| Laborie Medical Technologies Corp. | $16.21 | 2025 | Optilume Bph Drug Coated Balloon Catheter |
| Immunitybio, INC. | $15.57 | 2025 | |
| Becton, Dickinson and Company | $15.00 | 2025 | Bard X-Force Balloon Dilation Catheter |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Ilinsky listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.